December 4, 2024Expert Opinion on Drug Discovery

Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5

View Full Paper

Ask AI

Bookmark

Why the study?

Blood pressure control remains suboptimal despite available medications, while KV7.4 and KV7.5 channels have emerged as potential regulators of vascular tone and blood pressure.

Design

Review

Authors

JLJana LemkeUniversitätsmedizin Greifswald MGMaik GollaschVascular Medicine DTD TsvetkovMedical University of Varna

Discussion

Member takes

Implication

May identify novel antihypertensive targets; leaves open clinical translation pending trials.

Structured PICO

Intervention

KV7.4 and KV7.5 channel modulators (including flupirtine or retigabine derivatives)

The development of selective KV7.4 and KV7.5 channel modulators offers a potential novel pharmacological approach for the treatment of hypertension.

Limitations

Subtype channel selectivity has only been demonstrated for a handful of individual compounds
Need for discovery of new highly active, less toxic, and selective compounds

Cite This Study

Lemke et al. (2024) studied this question.

synapsesocial.com/papers/6a7100e8e71d69abee08fce2 https://doi.org/10.1080/17460441.2024.2438226

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Topics

Advances in the design and development of chemical modulators of the voltage-gated potassium channels K V 7.4 and K V 7.5

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider